Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Functional and binding studies with muscarinic M2-subtype selective antagonists.

S Lazareno1, F F Roberts

  • 1Department of Neuropharmacology, Glaxo Group Research Ltd., Herts.

British Journal of Pharmacology
|September 1, 1989
PubMed
Summary

This study compares muscarinic antagonist potencies on functional and binding preparations. Results suggest that functionally measured M2 receptor subtypes align with those identified through binding studies, supporting a refined classification.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Alkylamine treatment of leukaemia and Hodgkin's disease.

Lancet (London, England)·2010
Same author

Allosteric modulation of the muscarinic M4 receptor as an approach to treating schizophrenia.

Proceedings of the National Academy of Sciences of the United States of America·2008
Same author

Allosterism at muscarinic receptors: ligands and mechanisms.

Mini reviews in medicinal chemistry·2005
Same author

Thiochrome enhances acetylcholine affinity at muscarinic M4 receptors: receptor subtype selectivity via cooperativity rather than affinity.

Molecular pharmacology·2004
Same author

Analogs of WIN 62,577 define a second allosteric site on muscarinic receptors.

Molecular pharmacology·2002
Same author

Quantification of receptor interactions using binding methods.

Journal of receptor and signal transduction research·2002

Area of Science:

  • Pharmacology
  • Neuroscience
  • Receptor Biology

Background:

  • Muscarinic receptors are crucial for various physiological processes.
  • Understanding muscarinic receptor subtypes (M1-M5) is vital for developing selective therapeutics.
  • Previous studies suggest heterogeneity within the M2 receptor subtype.

Purpose of the Study:

  • To determine if functionally measured M2 receptor subtypes correspond to those identified in binding assays.
  • To compare the selectivity profiles of various muscarinic antagonists on isolated tissues and receptor binding sites.
  • To investigate the potential for extending the M2/M3 subtype classification to functionally defined receptors.

Main Methods:

  • Measurement of muscarinic antagonist potency on isolated rat ileum and atria preparations.

Related Experiment Videos

  • Radioligand binding studies using [3H]-N-methyl scopolamine and [3H]-pirenzepine on rat heart, submandibular gland, and cerebral cortex membranes.
  • Correlation analysis of antagonist potencies between functional and binding assays.

    • Main Results:

    • Selective muscarinic antagonists exhibited distinct potency profiles on rat ileum versus atria.
    • Binding affinities of antagonists to rat heart membranes closely correlated with their potencies on rat atria (r=0.98).
    • Binding affinities to rat submandibular gland membranes correlated well with potencies on rat ileum (r=0.97).
    • Himbacine demonstrated selective affinity for heart M2 sites over cerebral cortex M1 sites.
    • Functional and binding data supported the existence of three distinct muscarinic receptor subtypes.

    Conclusions:

    • Functionally identified M2 receptor subtypes are consistent with those characterized by binding studies.
    • The findings support the extension of the M2/M3 subtype classification to functionally defined receptors.
    • This research provides a basis for more precise pharmacological targeting of muscarinic receptor subtypes.